| |
| |
|
| Insider
Information: |
Smith Jason Drew |
| Relationship: |
General Counsel |
| City: |
Princeton |
| State: |
NJ |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
23,414 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$310,704 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
23,414 |
|
|
| Total
Value |
$310,704 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
|
|
| Stock
price went down : |
|
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Urogen Pharma Ltd. |
URGN |
General Counsel |
2024-02-01 |
23,414 |
2021-05-17 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
12 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| URGN |
Urogen Pharma Ltd. |
General Counsel |
• • – |
2024-02-01 |
4/A |
S |
$15.78 |
$78,790 |
D/D |
(4,993) |
23,414 |
0 |
- |
|
| URGN |
Urogen Pharma Ltd. |
General Counsel |
• • – |
2024-01-31 |
4 |
S |
$15.74 |
$78,590 |
D/D |
(4,993) |
23,414 |
0 |
% |
|
| URGN |
Urogen Pharma Ltd. |
General Counsel |
• • – |
2024-01-31 |
4 |
OE |
$0.00 |
$0 |
D/D |
10,000 |
26,742 |
0 |
- |
|
| URGN |
Urogen Pharma Ltd. |
General Counsel |
• • – |
2023-08-31 |
4 |
S |
$18.01 |
$68,438 |
D/D |
(3,800) |
18,407 |
0 |
% |
|
| URGN |
Urogen Pharma Ltd. |
General Counsel |
• • – |
2023-08-31 |
4 |
OE |
$0.00 |
$0 |
D/D |
8,334 |
22,207 |
0 |
- |
|
| URGN |
Urogen Pharma Ltd. |
General Counsel |
• • – |
2023-01-31 |
4 |
S |
$10.12 |
$16,556 |
D/D |
(1,636) |
13,873 |
0 |
% |
|
| URGN |
Urogen Pharma Ltd. |
General Counsel |
• • – |
2023-01-31 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,333 |
15,100 |
0 |
- |
|
| URGN |
Urogen Pharma Ltd. |
General Counsel |
• • – |
2022-08-31 |
4 |
S |
$7.21 |
$25,999 |
D/D |
(3,606) |
12,176 |
0 |
% |
|
| URGN |
Urogen Pharma Ltd. |
General Counsel |
• • – |
2022-08-31 |
4 |
OE |
$0.00 |
$0 |
D/D |
8,333 |
15,782 |
0 |
- |
|
| URGN |
Urogen Pharma Ltd. |
General Counsel |
• – – |
2022-01-31 |
4 |
S |
$7.58 |
$3,138 |
D/D |
(414) |
7,449 |
0 |
% |
|
| URGN |
Urogen Pharma Ltd. |
General Counsel |
• – – |
2022-01-31 |
4 |
OE |
$0.00 |
$0 |
D/D |
833 |
7,863 |
0 |
- |
|
| URGN |
Urogen Pharma Ltd. |
General Counsel |
• – – |
2021-05-17 |
4 |
B |
$15.71 |
$39,275 |
D/D |
2,500 |
2,500 |
2.74 |
% |
|
12 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
